Diamond Biofund Inc. (TPE:6901)

Diamond Biofund Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,533	2,756	126.23	2,103	333.84	18.14
Short-Term Investments	-	-	3,100	-	-	4.5
Trading Asset Securities	4,690	1,135	1,904	7,544	10,404	10,065
Cash & Short-Term Investments	7,224	3,891	5,130	9,647	10,738	10,087
Cash Growth	56.86%	-24.15%	-46.82%	-10.16%	6.45%	51.30%
Accounts Receivable	3.99	3.87	-	-	1.87	1.69
Other Receivables	10.06	8.33	7.74	2.64	0.21	-
Receivables	14.05	12.2	7.74	2.64	2.08	1.69
Other Current Assets	3.6	2.91	1.78	6	0.59	0.08
Total Current Assets	7,242	3,906	5,140	9,656	10,741	10,089
Property, Plant & Equipment	78.55	91.56	134.99	124.81	5.7	43.87
Long-Term Investments	5,097	5,340	5,391	3,235	445.28	406.09
Other Intangible Assets	0.37	0.26	0.25	0.14	0.28	-
Long-Term Accounts Receivable	9.5	11.52	-	-	-	-
Long-Term Deferred Tax Assets	0.03	0.02	-	-	-	-
Other Long-Term Assets	9.06	9.06	9.04	25.77	2.59	83.68
Total Assets	12,436	9,359	10,675	13,042	11,194	10,623

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	-	18.91	-	-	-
Current Portion of Leases	25.18	24.81	23.9	15.23	3.67	8.73
Current Income Taxes Payable	-	-	120.68	-	83.26	105.58
Other Current Liabilities	44.26	43.83	44.13	50.73	57.13	83.24
Total Current Liabilities	69.44	68.64	207.62	65.96	144.06	197.55
Long-Term Leases	56.53	69.12	93.93	113.78	-	33.26
Long-Term Deferred Tax Liabilities	0.03	0.02	-	-	-	-
Total Liabilities	126	137.79	301.55	179.74	144.06	230.82

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8,534	8,528	8,514	8,499	6,350	5,000
Additional Paid-In Capital	1,887	2,886	3,544	3,530	12.75	1.16
Retained Earnings	1,890	-2,193	-1,685	833.05	4,688	5,391
Shareholders' Equity	12,310	9,221	10,373	12,862	11,050	10,392
Total Liabilities & Equity	12,436	9,359	10,675	13,042	11,194	10,623

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	81.72	93.93	117.83	129.01	3.67	41.99
Net Cash (Debt)	7,142	3,797	5,012	9,518	10,734	10,045
Net Cash Growth	58.74%	-24.24%	-47.34%	-11.33%	6.86%	51.82%
Net Cash Per Share	8.29	4.46	5.89	12.22	13.95	12.41
Filing Date Shares Outstanding	853.36	852.75	851.39	849.89	749.3	749.3
Total Common Shares Outstanding	853.36	852.75	851.39	849.89	749.3	749.3
Working Capital	7,172	3,838	4,932	9,590	10,597	9,892
Book Value Per Share	14.43	10.81	12.18	15.13	14.75	13.87
Tangible Book Value	12,310	9,221	10,373	12,862	11,050	10,392
Tangible Book Value Per Share	14.43	10.81	12.18	15.13	14.75	13.87

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error